Chemotherapy in developing countries - Is less better?

European Journal of Cancer

Volumn 39, Issue 11, 2003, Pages 1497-1500

  Magrath, I ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER SURVIVAL; CARCINOMA; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; COST CONTROL; DEVELOPING COUNTRY; EDITORIAL; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; MAINTENANCE THERAPY; MAXIMUM TOLERATED DOSE; META ANALYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0038307779     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00296-X     Document Type: Editorial

References (19)

1. Taningher M., Malacarne D., Izzotti A., Ugolini D., Parodi S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436:1999;227-261.
2. Krajinovic M., Labuda D., Sinnett D. Childhood acute lymphoblastic leukemia. genetic determinants of susceptibility and disease outcome Rev. Environ. Health. 16:2001;263-279.
3. Flatt P.M., Pietenpol J.A. Mechanisms of cell-cycle checkpoints. at the crossroads of carcinogenesis and drug discovery Drug Metab. Rev. 32:2000;283-305.
4. Advani S.H., Banavali S.D. Pattern of infection in hematologic malignancies. an Indian experience Rev. Infect. Dis. 11(Suppl. 7):1989;S1621-S1628.
5. Odida M., Schmauz R., Lwanga S.K. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity. Int. J. Cancer. 99:2002;737-741.
6. Patil A.V., Somasundaram K.V., Goyal R.C. Current health scenario in rural India. Aust. J. Rural Health. 10:2002;129-135.
7. Advani S., Pai S., Venzon D.et al. Acute lymphoblastic leukemia in India. an analysis of prognostic factors using a single treatment regimen Ann. Oncol. 10:1999;167-176.
8. Stewart B.W., Kleihues P. World Cancer Report. 2003;IARC Publications, Lyon, France.
9. Chandy M. Childhood acute lymphoblastic leukemia in India. an approach to management in a three-tier society Med. Pediatr. Oncol. 25:1995;197-203.
10. Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst. Rev. 1:2002;CD000487.
11. Souhami R.L., Craft A.W., Van der Eijken J.W.et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma. a study of the European Osteosarcoma Intergroup Lancet. 350:1997;911-917.
12. Viens P., Maraninchi D. High-dose chemotherapy in advanced breast cancer. Crit. Rev. Oncol. Hematol. 41:2002;141-149.
13. Farquhar C., Basser R., Marjoribanks J.et al. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer (Cochrane Review). Cochrane Database Syst. Rev. 1:2003;CD003139.
14. Pui C.H., Gaynon P.S., Boyett J.M.et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 359:2002;1909-1915.
15. Schellong G., Bramswig J.H., Hornig-Franz I. Treatment of children with Hodgkin's disease - results of the German Pediatric Oncology Group. Ann. Oncol. 3(Suppl. 4):1992;73-76.
16. Ziegler J.L. Burkitt's lymphoma. N. Engl. J. Med. 305:1981;735-745.
17. Magrath I.T., Adde M., Shad A.et al. Adults and children with small noncleaved cell lymphoma have a similar, excellent outcome when treated with the same chemotherapy regimen. J. Clin. Oncol. 14:1996;925-934.
18. Inamdar N., Kumar S.A., Banavali S.D.et al. Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. Int. J. Oncol. 13:1998;1319-1322.
19. Wilimas J.A., Ribeiro R.C. Pediatric haematology-oncology outreach for developing countries. Hematol. Oncol. Clin. North. Am. 2001;775-787.